Icagen, Inc.

UEI: LJMTDWLU8VK3
CAGE: 3VSW2
Primary NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration: Expired Sep 11, 2020

Company facts

Self-certified in SAM.gov: For Profit Organization
Entity structure: Corporate Entity (Not Tax Exempt)
Corporate family: Icagen, Inc.

Icagen-T, Inc. T2HRQJP6L694
SAM.gov registration date: May 19, 2004

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Mar 7, 2021.

Contract awards

Award	Agency	Obligated	Awarded
Sbir phase i topic 339 systemic targeted radionuclide therapy for cancer treatment period of performance: 09/22/2015… HHSN261201500050C	National Cancer Institute (NIH)	$300,000	Sep 22, 2015
Sbir phase i FA822212C0018	Air Force Sustainment Center (AFMC)	$150,000	Aug 13, 2012
Scientific research services W911NF09C0162	ACC Aberdeen Proving Ground	$100,000	Sep 22, 2009
Scientific research services W911NF09C0100	ACC Aberdeen Proving Ground	$100,000	Sep 3, 2009
Biomolecular taggants for covert tracking and watermarking FA875009C0043	Air Force Research Laboratory (AFMC)	$736,289	Feb 17, 2009

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award	Agency	Obligated	Awarded
Xrpro radioactive cesium decorporation agents R43AI091186	National Institutes of Health	$600,000	Jul 1, 2014
Xrpro technology for the detection and evaluation of carcinogens R43CA150404	National Institutes of Health	$200,000	Aug 6, 2010
Probes for transient kinase complexes R43GM090387	National Institutes of Health	$98,917	Mar 1, 2010
Xrpro discovery of decorporation agents R43AI079935	National Institutes of Health	$600,000	Feb 1, 2009
Selective decorporation agents for niaid R44AI079935	National Institutes of Health	$2,931,922	Apr 1, 2008

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Icagen, Inc. registered in SAM.gov?

Icagen, Inc.'s SAM.gov registration expired on September 11, 2020.

What is Icagen, Inc.'s most recent federal award?

Icagen, Inc.'s most recent federal contract award is Sbir phase i topic 339 systemic targeted radionuclide therapy for cancer treatment period of performance: 09/22/2015… (HHSN261201500050C), from National Cancer Institute (NIH), on September 22, 2015.

On GovTribe

See Icagen, Inc.'s full federal record

Federal contract awards
Federal grant awards
Funding analysis by agency, NAICS and set-aside
Similar vendors

Try for free Login